Senior insider sale
Chief Financial Officer at VERONA PHARMA PLC — senior position signals high conviction
$14.20M
184.67K shares
What this filing means
HAHN MARK W plans to sell 184.67K shares of VERONA PHARMA PLC valued at approximately $14.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/11/2025ACC: 0001950047-25-004154
Officer· Chief Financial Officer
Since Jan 2021
184.67K
Shares to sell
$14.20M
Approx. market value
50K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/1/2021
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2021 | Restricted Stock Units N/A | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
25.61K
Market value
$1.91M
5/29/2025
—Completed
Units to sell
20.34K
Market value
$1.51M
5/28/2025
—Completed
Units to sell
4.05K
Market value
$309.0K
5/27/2025
—Completed
Units to sell
50K
Market value
$3.64M
5/2/2025
—Completed
Units to sell
23.38K
Market value
$1.67M
5/1/2025
—Completed
Units to sell
11.29K
Market value
$811.4K
4/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$4.34M
6/11/2025
Total
Units
184.67K
Value
$14.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/29/2025 | 25.61K | $1.91M | — | Completed |
5/28/2025 | 20.34K | $1.51M | — | Completed |
5/27/2025 | 4.05K | $309.0K | — | Completed |
5/2/2025 | 50K | $3.64M | — | Completed |
5/1/2025 | 23.38K | $1.67M | — | Completed |
4/29/2025 | 11.29K | $811.4K | — | Completed |
| Planned — Approximate Date | ||||
6/11/2025 | 50K | $4.34M | NASDAQ | Planned |
| Total | 184.67K | $14.20M | ||